ATE464043T1 - Pharmazeutische zusammensetzung enthaltend l- arginin - Google Patents
Pharmazeutische zusammensetzung enthaltend l- argininInfo
- Publication number
- ATE464043T1 ATE464043T1 AT02774591T AT02774591T ATE464043T1 AT E464043 T1 ATE464043 T1 AT E464043T1 AT 02774591 T AT02774591 T AT 02774591T AT 02774591 T AT02774591 T AT 02774591T AT E464043 T1 ATE464043 T1 AT E464043T1
- Authority
- AT
- Austria
- Prior art keywords
- arginine
- pharmaceutical composition
- composition containing
- pharmaceutically acceptable
- solid form
- Prior art date
Links
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229930064664 L-arginine Natural products 0.000 abstract 3
- 235000014852 L-arginine Nutrition 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 150000007524 organic acids Chemical class 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0209395 | 2002-08-22 | ||
PCT/EP2002/010147 WO2004017955A1 (en) | 2002-08-22 | 2002-09-10 | L-arginine containing pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE464043T1 true ATE464043T1 (de) | 2010-04-15 |
Family
ID=31896810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02774591T ATE464043T1 (de) | 2002-08-22 | 2002-09-10 | Pharmazeutische zusammensetzung enthaltend l- arginin |
Country Status (3)
Country | Link |
---|---|
AT (1) | ATE464043T1 (de) |
DE (1) | DE60236025D1 (de) |
WO (1) | WO2004017955A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005018620A2 (en) * | 2003-08-26 | 2005-03-03 | Cell Center Cologne Gmbh | Use of nitric oxide synthase (nos) cofactor for the treatment of sexual dysfunction |
ES2596827T3 (es) | 2003-11-17 | 2017-01-12 | Biomarin Pharmaceutical Inc. | Tratamiento de la fenilcetonuria con BH4 |
EP1964566A4 (de) * | 2005-12-22 | 2009-01-07 | Asubio Pharma Co Ltd | Zubereitung mit verbesserter bioabsorption von sapropterin-hydrochlorid |
US10842813B2 (en) | 2007-02-26 | 2020-11-24 | Heartbeet Ltd | Compositions of nitrates and methods of use thereof |
US11759477B2 (en) | 2007-02-26 | 2023-09-19 | Heartbeet Ltd. | Compositions of nitrates and methods of use thereof |
AU2009212337B2 (en) * | 2008-02-08 | 2012-01-12 | Colgate-Palmolive Company | Cleaning compositions and methods |
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
EP2456432B1 (de) | 2009-07-22 | 2024-02-28 | University of Massachusetts | Zusammensetzungen zur verringerung von oxidativem stress |
CN103429247A (zh) | 2010-12-29 | 2013-12-04 | 战略科学与技术有限责任公司 | 勃起功能障碍和其它适应症的治疗 |
US9216178B2 (en) | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
CN104902914B (zh) * | 2012-09-11 | 2019-01-01 | 科荣生生物科学公司 | 高纯度和优异产量的正确折叠的依那西普 |
EP4158351A1 (de) * | 2020-05-25 | 2023-04-05 | Universiteit Maastricht | Verfahren zur diagnose und behandlung von essentieller primärer hypertonie |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0908182B2 (de) * | 1996-08-30 | 2007-03-28 | Daiichi Asubio Pharma Co., Ltd. | Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind |
US6063432A (en) * | 1998-05-19 | 2000-05-16 | Cooke Pharma | Arginine or lysine containing fruit healthbar formulation |
ES2258426T3 (es) * | 2000-06-16 | 2006-09-01 | Matthias Dr. Med. Rath | Composicion para la prevencion de enfermedades de los musculos lisos que comprenden ascorbato, arginina y magnesio. |
US6552074B2 (en) * | 2000-11-16 | 2003-04-22 | Fukumi Morishige | Arginine/ascorbic acid mixed powder as an oral supplement |
-
2002
- 2002-09-10 DE DE60236025T patent/DE60236025D1/de not_active Expired - Lifetime
- 2002-09-10 AT AT02774591T patent/ATE464043T1/de not_active IP Right Cessation
- 2002-09-10 WO PCT/EP2002/010147 patent/WO2004017955A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
DE60236025D1 (de) | 2010-05-27 |
WO2004017955A1 (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062644L (no) | DPP-IV inhibitorer | |
MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
ATE303149T1 (de) | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil | |
DE60236025D1 (de) | Pharmazeutische zusammensetzung enthaltend l-arginin | |
BRPI0410219A (pt) | composições farmacêuticas de vareniclina | |
HUP0201083A2 (hu) | Új atorvastatinsók és az azokat tartalmazó gyógyszerkészítmények | |
UA93529C2 (ru) | Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами | |
ATE528009T1 (de) | Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten | |
DE60121804D1 (de) | Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin | |
DE60319707D1 (de) | Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose | |
GB0212410D0 (en) | Organic compounds | |
EA200300272A1 (ru) | Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их | |
BRPI0407519A (pt) | derivados de benzofurano | |
RS51578B (en) | SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITROMYCIN | |
TW200502235A (en) | Novel benzo[1,2,5]thiadiazoles and pharmaceutical use thereof | |
ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
ATE275577T1 (de) | Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung | |
EP1325918A4 (de) | Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten | |
JP2004523567A5 (de) | ||
BRPI0510704A (pt) | tienopiridazinas como inibidores de ikk | |
EA200401082A1 (ru) | Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат | |
MXPA04002640A (es) | Esteres de analogos de 3-desoxi-vitamina d3. | |
ATE356118T1 (de) | Moexipril-magnesium enthaltende arzneimittel | |
BR0213463A (pt) | Composições farmacêuticas contendo macrólidos | |
TW200509941A (en) | Pharmaceutical solution composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |